300633 开立医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.37715.44214.51613.364-3.370
总资产报酬率 ROA (%)4.28512.42411.2679.379-1.983
投入资产回报率 ROIC (%)4.93514.36013.22911.268-2.571

边际利润分析
销售毛利率 (%)67.42869.41166.86667.38266.445
营业利润率 (%)17.45922.39421.69614.929-3.798
息税前利润/营业总收入 (%)14.57820.24119.97318.229-1.094
净利润/营业总收入 (%)16.84421.43320.98017.115-3.978

收益指标分析
经营活动净收益/利润总额(%)79.23096.02389.84591.386-208.596
价值变动净收益/利润总额(%)-0.268-2.7101.3935.902-61.931
营业外收支净额/利润总额(%)-0.100-0.208-0.12715.1630.823

偿债能力分析
流动比率 (X)3.3084.6173.3553.8361.801
速动比率 (X)2.5593.6822.6693.0441.426
资产负债率 (%)23.68416.58422.69722.02340.274
带息债务/全部投入资本 (%)10.7261.8928.8004.165--
股东权益/带息债务 (%)817.2825,093.5281,016.0202,238.482279.477
股东权益/负债合计 (%)322.228502.980340.596354.069148.302
利息保障倍数 (X)-5.091-9.606-11.77828.865-0.400

营运能力分析
应收账款周转天数 (天)35.92931.65941.57156.6420.000
存货周转天数 (天)327.768290.268294.299286.9650.000